Human Oncogenic Viruses (HOVs) cause 17% of all cancer in humans. Most of these viruses cause common infections and their associated malignancy is only a rare end result. Their oncogenic mechanisms are diverse and complex, but research into these mechanisms is identifying new insights which have the potential to be translated into new strategies to treat viruses and their cancer.
Grech et al. (Sun,) studied this question.